 |
|
|
 |
GEMAC develops innovative therapies for the treatment
of chronic diseases using endogenous small molecules.
GEMAC turns these small molecules into therapeutic
products for Central Nervous System disorders and
autoimmune diseases.
So far GEMAC is focusing on two pathologies:
Using the same technology, Gemac’s team will
be able to explore other pathologies in the future.
|
|
|
